September 21, 2014 5:29 AM ET

Pharmaceuticals

Company Overview of TAXIS Pharmaceuticals, Inc.

Executive Profile

Daniel S. Pilch Ph.D.

Co-Founder and Director, TAXIS Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Daniel S. Pilch, Ph.D co-founded TAXIS Pharmaceuticals, Inc. in 2009 and serves as Director. Mr. Pilch is currently a member of the Editorial Board of the journal Perspectives in Medicinal Chemistry and serves as the Editor-in-Chief of the journal Drug Design, Development and Therapy. Mr. Pilch is an Associate Professor of Pharmacology at the Robert Wood Johnson Medical School of UMDNJ, with a joint appointment in the Department of Chemistry and Chemical Biology at Rutgers ...

Corporate Headquarters

675 US Highway 1
North Brunswick, New Jersey 08902

United States

Phone: 732-729-6230
Fax: --

Board Members Memberships

Co-Founder and Director

Education

BA
University of California Berkeley
PhD
University of California-San Francisco

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAXIS Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.